Literature DB >> 92550

Intrathecal IgG synthesis in multiple sclerosis and other neurological diseases: a comparative evaluation by IgG-index and isoelectric focusing.

M Poloni, B Rocchelli, R Scelsi, P Pinelli.   

Abstract

Intrathecal IgG synthesis has been investigated by determining the IgG index and by isoelectric focusing in 30 cases of definite multiple sclerosis, in 15 cases of probable multiple sclerosis and in 128 patients affected by other neurological diseases. The blood-brain barrier function was evaluated at the same time by serum albumin/CSF albumin quotient and isoelectric focusing. The IgG index was found elevated in 73.3% of definite multiple sclerosis patients, while oligoclonal IgG bands occurred in 90%. In the other neurological diseases the IgG index was abnormally increased in 35.1% but IgG bands were present only in cerebrospinal fluid (CSF) in 1.5% and both in the CSF and serum in 7% of patients. The high capacity of isoelectric focusing to detect IgG oligoclonal bands in the CSF is pointed out as an extremely useful diagnostic tool in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92550     DOI: 10.1007/bf00314641

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Comparison between agarose gel electrophoresis and isoelectric focusing of CSF for demonstration of oligoclonal immunoglobulin bands in neurological disorders.

Authors:  M A Laurenzi; H Link
Journal:  Acta Neurol Scand       Date:  1978-09       Impact factor: 3.209

3.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

4.  Immunoglobulin synthesis within the central nervous system in disseminated sclerosis.

Authors:  S Cohen; R Bannister
Journal:  Lancet       Date:  1967-02-08       Impact factor: 79.321

5.  Isoelectric focusing of CSF proteins in neurological diseases.

Authors:  K G Kjellin; O Vesterberg
Journal:  J Neurol Sci       Date:  1974-10       Impact factor: 3.181

6.  [Paper and agar gel electrophoresis of the cerebrospinal fluid proteins in multiple sclerosis and other neurological diseases. Results in 266 cases].

Authors:  J Stenuit; P Delmotte
Journal:  Acta Neurol Belg       Date:  1972 Jul-Aug       Impact factor: 2.396

7.  Separation of the proteins of cerebrospinal fluid using gel electrofocusing followed by electrophoresis.

Authors:  C Fossard; G Dale; A L Latner
Journal:  J Clin Pathol       Date:  1970-10       Impact factor: 3.411

8.  Relationships between abnormal IgG index, oligoclonal bands, acute phase reactants and some clinical data in multiple sclerosis.

Authors:  O Christensen; J Clausen; T Fog
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

9.  Aberrant CSF protein fractions found by electrofocusing in multiple sclerosis. A study of 26 cases with clinically verified or probable multiple sclerosis and 2 cases with optic neuritis.

Authors:  K G Kjellin; A Siden
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

10.  Immunoglobulins in multiple sclerosis and infections of the nervous system.

Authors:  H Link; R Müller
Journal:  Arch Neurol       Date:  1971-10
View more
  12 in total

Review 1.  Neuronal surface antibody-mediated autoimmune encephalitis.

Authors:  Jenny J Linnoila; Myrna R Rosenfeld; Josep Dalmau
Journal:  Semin Neurol       Date:  2014-11-04       Impact factor: 3.420

2.  Intrathecal IgG synthesis in multiple sclerosis: comparison between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgG.

Authors:  P Livrea; M Trojano; I L Simone; G B Zimatore; G Lamontanara; R Leante
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

3.  Cerebrospinal fluid IgG changes in subacute sclerosing panencephalitis in the various stages of the disease and during isoprinosine therapy.

Authors:  M Poloni; B Rocchelli; G Lanzi; F Rosano Burgio; D Besana
Journal:  Ital J Neurol Sci       Date:  1981-05

4.  Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.

Authors:  B Rocchelli; M Poloni; P Mazzarello; G Piccolo; M Delodovici; P Pinelli
Journal:  Ital J Neurol Sci       Date:  1982-07

5.  Antibody synthesis within the central nervous system: comparisons of CSF IgG indices and electrophoresis.

Authors:  E J Thompson; P G Riches; J Kohn
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

6.  On the diagnostic value of different CSF investigations in multiple sclerosis.

Authors:  K Lauer
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

7.  Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

Authors:  O G Segurado; H Krüger; H G Mertens
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

8.  Intrathecal immunoglobulin synthesis in cerebral malaria.

Authors:  H M Chapel; D A Warrell; S Looareesuwan; N J White; R E Phillips; M J Warrell; V Supawanta; S Tharavanij
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

9.  Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.

Authors:  R W Walker; E J Thompson; W I McDonald
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

10.  CFS oligoclonal bands in MS and other neurological diseases detected by agarose isoelectric focusing and electrophoresis.

Authors:  D Cerrato; A Salmaggi; C Ariano; L La Mantia; A Nespolo
Journal:  Ital J Neurol Sci       Date:  1984-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.